Volume : 9, Issue : 6, June - 2020

Levobupivacaine: Pharmacological review

Dr. Arjun Singh

Abstract :

The quest for searching newer and safer anesthetic agents has always been one of the primary needs in anesthesiology practice. Levobupivacaine is the S (−)-enantiomer of bupivacaine, has strongly emerged as a safer alternative for regional anesthesia than its racemic sibling, bupivacaine. Most adverse effects are related to faulty administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia; however, allergic reactions can also occur rarely. The present review aims to discuss the pharmacological profile of levobupivacaine.